Cost: Free of charge Language: English
Factorytalk is proud to announce that David Margetts, Group Executive Director at Factorytalk, will be speaking at the MOPI Webinar 1–2026: Artificial Intelligence in the Pharmaceutical Industry.
In this session, David will bring AI down from abstraction and place it firmly within real pharmaceutical production environments—demonstrating how data, systems, and decision-making are evolving inside regulated manufacturing.
What This Session Will Cover
1. AI Trends in Pharmaceutical Manufacturing
What is actually happening today?
Where is AI already being deployed — and where is it still experimental?
2. Types of AI That Fit Regulated Manufacturing
Which technologies are suitable for GxP environments — and why?
3. From Concept to Production: Making AI Real
How to translate AI from a strategic discussion into practical deployment.
How data flows, operational systems, and decision-making processes change when AI is introduced.
4. ROI and the Cost Question
Cost remains one of the biggest barriers to AI adoption.
This session explores how to evaluate ROI and ensure AI expands the business—rather than adding unnecessary complexity.
5. AI Adoption Policy & Governance
What organisations must consider before enabling AI use in regulated environments, including governance, risk control, and responsible adoption.
Why This Matters Now
Pharmaceutical manufacturers face increasing pressure to:
- Improve efficiency
- Maintain inspection readiness
- Protect data integrity
- Expand capacity without increasing risk
Understanding where AI genuinely adds value — and where it doesn’t — is now a strategic capability for manufacturing leaders.
